UK Select Country
For Help or to Order
Call Now!

TRX2 (trichos=hair in ancient greek; 2=second generation) is one of the world’s leading research projects exclusively devoted to providing a new standard of care for the treatment of Androgenetic Alopecia (AGA). The project has been made possible through Oxford BioLabs Ltd. and former scientists from the University of Oxford, UK. TRX2 follows several independent research paths including:

1) Hair growth

2) The prevention of hair loss

3) A cure against Androgentic Alopecia and other hair growth disorders

For our ongoing and past research projects please visit our Research page.

Mission & Goal

Our mission is to create an extraordinary customer experience by tackling Androgenetic Alopecia (AGA) through high-performance, cutting-edge science that delivers noticeable, honest results. Our goal is to create the new standard of care for the treatment of AGA.

Company Background

TRX2 is run by Oxford BioLabs. The company was founded in August 2008 by former scientists from the University of Oxford and is incorporated as a Limited Liability Company in England & Wales. Oxford is one of the world’s leading centers for biochemical research and the commercialization of new technologies.


We are a team of scientists and medical authorities brought together by a shared aspiration: to challenge the status quo and end the frustrations of people suffering from hair loss. Our team consists of a growing number of

  • World leading scientists in the field of potassium channel research
  • Dermatologists and experts in the field of androgentic alopecia
  • Medical professionals and surgeons

Scientific Lead: Dr. Thomas F.A. Whitfield DPhil

Dr. Whitfield has been an academic visitor at the University of Oxford’s Department of Biochemistry and is an internationally recognized expert in potassium channel research and the molecular mechanism of Androgenetic Alopecia. He is author of multiple peer-reviewed publications and international patents in the field of potassium channel research and Androgenetic Alopecia. Dr. Whitfield holds a DPhil in  Biochemistry from the University of Oxford.


TRX2 takes advantage of the latest scientific knowledge of the molecular mechanism behind male and female pattern hair loss. The chronic blockage of potassium channels in hair follicles is a cause of hair loss.

TRX2 has world-class expertise and many years of experience in the field of potassium channel research and the molecular mechanism of male and female pattern hair loss. Please visit our Scientific Articles to view a selection of our publications and credentials in the field.


Oxford BioLabs Ltd. received a grant award in 2009 from the National Council for Graduate Entrepreneurship (NGCE) Flying Start Entrepreneur fund. This fund was supported by the National Endowment for Science, Technology and the Arts (NESTA). For more information about NGCE and NESTA see below:


trx2 investor

NCGE – National Council For Graduate Entrepreneurship

The NCGE is a council group based on Birmingham, UK whose purpose is to develop and promote a culture of entrepreneurship through research, education and facilitation.

Read more about NCGE


trx2 investor

NESTA – the UK’s leading independent expert on innovation

NESTA works with public, private and third-sector partners bringing together powerful combinations of people, resources and bright ideas. NESTA combines capital investment with non-financial support to help the UK’s innovative early-stage companies turn their ideas into commercial success.

Read more about NESTA



oxford enterpreuner        

oxford enterpreuner       

See who's talking about TRX2®

* These statements have not been evaluated by the medicines regulatory agencies. This product is not a drug or medicine, and is not intended to diagnose, treat, cure or prevent any disease. This patent-pending food supplement contains nutrients that help maintain normal healthy hair. Zinc, selenium and biotin contribute to the maintenance of normal hair. Normal hair is also characterised by healthy hair growth and non-excessive hair loss. Results may vary and are subject to your individual metabolism. If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before using this product. Regarding risks and side-effects please see the package insert and ask your physician or healthcare specialist. Read full disclaimer. Read Legal Notices.

Disclaimer: The entire contents of this website are based upon the opinions and research of Oxford Biolabs Ltd., unless otherwise noted. Individual articles are based upon the opinions of the respective author, who may retain copyright as marked. Statements related to the rejuvenation, activation and stimulation of potassium channels are not intended to promote any specific ingredient, regimen, or use and should not be construed as evidence of the safety, effectiveness, or intended uses of the TRX2® product. It is purely presented as information about Oxford Biolabs's research focus and rationality behind formulating the TRX2 food supplement. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Oxford Biolabs Ltd. and its community. Oxford Biolabs Ltd. encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. See our terms of service and privacy policy and full disclaimer here